| 以吡柔比星为主的药物经导管插管化疗及栓塞治疗肝癌的临床疗效观察 |
| |
| 引用本文： | 程祝忠,文华长,许国辉,文永君,杨承莲. 以吡柔比星为主的药物经导管插管化疗及栓塞治疗肝癌的临床疗效观察[J]. 中国肿瘤临床与康复, 1999, 0(6) |
| |
| 作者姓名： | 程祝忠 文华长 许国辉 文永君 杨承莲 |
| |
| 作者单位： | 四川省肿瘤医院影像科介入病房!610041 |
| |
| 摘 要： | 目的观察吡柔比星为主要药物经导管化疗加栓塞联合治疗晚期肝癌的疗效。方法以吡柔比星为主要药物经导管联合化疗加栓塞治疗晚期肝癌142例。结果近期有效率59％，AFP下降率71％，主要副作用为胃肠道反应。结论采用吡柔比星为主的药物联合化疗加栓塞冶疗晚期肝癌疗效满意，毒副作用低。
|
| 关 键 词： | 吡柔比星 化疗 栓塞 肝癌 |
Observation on clinical curative effect of chemotherapy mainly of pirarubicin and embolization hy catheterization in the treatment of bepatic cellular carcinoma |
| |
| Cheng Zhuzhong, Wen Huachang, Xu Guohui,et al.. Observation on clinical curative effect of chemotherapy mainly of pirarubicin and embolization hy catheterization in the treatment of bepatic cellular carcinoma[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 1999, 0(6) |
| |
| Authors: | Cheng Zhuzhong Wen Huachang Xu Guohui et al. |
| |
| Affiliation: | Cheng Zhuzhong, Wen Huachang, Xu Guohui, et al. |
| |
| Abstract: | To observe the clinical curative effect of chemotherapy malnly of piraru bicin and embolization by catheterlzation in the treatment of HCC. Methods l42 patients suffering from hepatic cellular carcimona (HCC ) underwent chemotherapy mainly of pirarubicin and emboliza tion by catheterization, lipiodol was well deposited in forty-five cases. Lipiodol was partly deposited in seventy-nine cases. Tumor resection was done in 5 patients after embolization. Results The short term effectiveness was 71 %. 24 cases manifested side effects of gastrointestinal tract. The WBC count reduced in 15 cases. 4 cases occurred arrythmia. 4 cases occured bradycardia. Conclusion The com bined chemotherapy mainly of pirarubicin and embolization will result in satisfied effect and avoid tox ic and side effects of various chemotherapeutic agents,it will be an ideal treatment. |
| |
| Keywords: | Pirarubicin Chemetherapy Embolization HCC |
| 本文献已被 CNKI 等数据库收录！ |
